MDGL logo

Madrigal Pharmaceuticals, Inc. (MDGL)

Profile

Full Name

Madrigal Pharmaceuticals, Inc.

Ticker

NASDAQ: MDGL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 6, 2007

Indexes

Not included

Website

https://www.madrigalpharma.com

Employees

528

Key Details

Price

$414.68(+1.86%)

Market cap

$9.24B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$180.13M(+100.00% YoY)

Annual EPS

-$21.90(-9.55% YoY)

PE ratio

-

Next earnings date

Oct 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $414.68
    MDGL price is $414.68

    30-Day Relative Volume

    1.01
    MDGL 30-day relative volume is 1.01

    Price Performance

    Price Most recent change

    +1.86%
    MDGL price was up +1.86% on Aug 22, 2025

    Price YTD change

    +34.39%
    MDGL price is up +34.39% since January 1st

    Price 1-year change

    +66.75%
    MDGL price is up +66.75% year-on-year

    Price 3-year change

    +490.63%
    MDGL price is up +490.63% over the past 3 years

    Price Range

    Price All-time high

    $419.99
    MDGL price is currently -1.26% below its historical high of $419.99

    Price 3-year low

    $57.21
    MDGL price is currently +624.84% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $9.24B
    MDGL market capitalization is $9.24 billion

    Market cap 3-year change

    +669.7%
    MDGL market capitalization is up +669.7% over the past 3 years

    Market cap All-time high

    $9.24B
    MDGL market capitalization is currently at an all-time high

    Market cap sector rank

    91.77%
    MDGL market capitalization is higher than 91.77% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.65%
    MDGL shares outstanding is up +2.65% year-on-year

    Shares Outstanding 3-Year Change

    +30.32%
    MDGL shares outstanding is up +30.32% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.82
    MDGL beta is 0.82

    200-day SMA

    $317.74
    MDGL price is currently +30.51% above its 200-day simple moving average

    50-day SMA

    $321.29
    MDGL price is currently +29.07% above its 50-day simple moving average

    RSI

    76.08
    MDGL 14-day relative strength index is 76.08

    Volume

    1.01
    MDGL 30-day relative volume is 1.01

    ATR

    $15.83
    MDGL average true range is $15.83

    10-day Historical Volatility

    42.00%
    MDGL 10-day historical volatility is 42.00%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $180.13M
    MDGL annual revenue is $180.13 million

    Revenue Analysts estimate

    $875.47M
    MDGL annual revenue is currently -79.42% lower than the consensus analysts' forecast

    Revenue 1-year change

    +100%
    MDGL annual revenue is up +100% year-on-year

    Revenue Sector rank

    72.94%
    MDGL annual revenue is higher than 72.94% of companies in Healthcare sector

    EPS

    EPS

    -$21.90
    MDGL annual earnings per share is -$21.90

    EPS Analysts estimate

    -$8.98
    MDGL annual earnings per share is currently +143.81% higher than the consensus analysts' forecast

    EPS 1-year change

    -9.55%
    MDGL annual earnings per share is down -9.55% year-on-year

    EPS Sector rank

    7.07%
    MDGL annual earnings per share is higher than 7.07% of companies in Healthcare sector

    Profit

    Gross profit

    $172.80M
    MDGL annual gross profit is $172.80 million

    Gross margin

    95.93%
    MDGL annual gross profit margin is 95.93%

    Operating profit

    -$497.88M
    MDGL annual operating income is -$497.88 million

    Operating margin

    -276.39%
    MDGL annual operating profit margin is -276.39%

    Net income

    -$465.89M
    MDGL annual net profit is -$465.89 million

    Net margin

    -258.64%
    MDGL annual net profit margin is -258.64%

    Expenses

    Total expenses

    $678.01M
    MDGL annual total expenses is $678.01 million

    Operating expenses

    $671.77M
    MDGL annual total operating expenses is $671.77 million

    Cost of goods sold

    $7.33M
    MDGL annual cost of goods sold is $7.33 million

    Selling, general & administrative expenses

    $0.00
    MDGL annual SGA is $0.00

    Depreciation and amortization

    $1.10M
    MDGL annual depreciation & amortization is $1.10 million

    Interest expense

    $0.00
    MDGL annual interest expense is $0.00

    Income tax

    $0.00
    MDGL annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$451.22M
    MDGL annual earnings before interest & taxes is -$451.22 million

    EBITDA

    -$450.13M
    MDGL annual EBITDA is -$450.13 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.04B
    MDGL annual total assets is $1.04 billion

    Non current assets

    $9.32M
    MDGL annual long term assets is $9.32 million

    Current assets

    $1.03B
    MDGL annual total current assets is $1.03 billion

    Cash and cash equivalents

    $931.25M
    MDGL annual cash & cash equivalents is $931.25 million

    Accounts receivable

    $53.82M
    MDGL annual accounts receivable is $53.82 million

    Inventory

    $34.07M
    MDGL annual inventory is $34.07 million

    Liabilities

    Total liabilities

    $287.86M
    MDGL annual total liabilities is $287.86 million

    Long term liabilities

    $118.59M
    MDGL annual total long term liabilities is $118.59 million

    Current liabilities

    $169.28M
    MDGL annual total current liabilities is $169.28 million

    Accounts payable

    $43.60M
    MDGL annual accounts payable is $43.60 million

    Debt

    Total debt

    $119.57M
    MDGL annual total debt is $119.57 million

    Total debt 1-year change

    +2.03%
    MDGL annual total debt is up +2.03% year-on-year

    Long term debt

    $118.59M
    MDGL annual long term debt is $118.59 million

    Short term debt

    $983.00K
    MDGL annual short term debt is $983.00 thousand

    Equity & Capital

    Shareholders equity

    $754.38M
    MDGL annual stockholders equity is $754.38 million

    Book value

    $754.38M
    MDGL annual book value is $754.38 million

    Retained earnings

    -$1.80B
    MDGL annual retained earnings is -$1.80 billion

    Working capital

    $863.65M
    MDGL annual working capital is $863.65 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$455.57M
    MDGL annual cash flow from operations is -$455.57 million

    Cash from operations 1-year change

    -40.51%
    MDGL annual cash flow from operations is down -40.51% year-on-year

    Cash from investing

    -$274.39M
    MDGL annual cash flow from investing activities is -$274.39 million

    Cash from investing 1-year change

    +45.4%
    MDGL annual cash flow from investing activities is up +45.4% year-on-year

    Cash from financing

    $735.06M
    MDGL annual cash flow from financing activities is $735.06 million

    Cash from financing 1-year change

    +23.52%
    MDGL annual cash flow from financing activities is up +23.52% year-on-year

    CAPEX

    CAPEX

    $6.46M
    MDGL annual capital expenditures is $6.46 million

    CAPEX 1-year change

    +336.92%
    MDGL annual capital expenditures is up +336.92% year-on-year

    Free Cash Flow

    Free cash flow

    -$462.03M
    MDGL annual free cash flow is -$462.03 million

    Free cash flow 1-year change

    -41.85%
    MDGL annual free cash flow is down -41.85% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    95.93%
    MDGL annual gross profit margin is 95.93%

    Operating margin

    -276.39%
    MDGL annual operating profit margin is -276.39%

    Net margin

    -258.64%
    MDGL annual net profit margin is -258.64%

    ROA & ROE

    ROA

    -55.37%
    MDGL annual return on assets is -55.37%

    ROE

    -80.35%
    MDGL annual return on equity is -80.35%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    MDGL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    MDGL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    13.28
    MDGL price to book ratio is 13.28

    PB ratio Sector rank

    91.82%
    MDGL price to book ratio is higher than 91.82% of companies in Healthcare sector

    PS Ratio

    PS ratio

    17.93
    MDGL price to sales ratio is 17.93

    PS ratio Sector rank

    80.34%
    MDGL price to sales ratio is higher than 80.34% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $8.56B
    MDGL enterprise value is $8.56 billion

    Enterprise value Sector rank

    90.88%
    MDGL enterprise value is higher than 90.88% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -27.77
    MDGL EV/EBITDA is -27.77

    EV/EBITDA Sector rank

    4.88%
    MDGL EV/EBITDA is higher than 4.88% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    6.10
    MDGL annual current ratio is 6.10

    Quick ratio

    5.90
    MDGL annual quick ratio is 5.90

    Leverage

    Debt to equity

    0.16
    MDGL annual debt to equity ratio is 0.16

    Interest coverage ratio

    -
    MDGL annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    MDGL piotroski f-score is 2

    Altman Z-Score

    16.58
    MDGL altman z-score is 16.58

    Analyst ratings

    Recent major analysts updates

    Aug 12, 25 UBS
    Buy
    Aug 6, 25 Canaccord Genuity
    Buy
    May 2, 25 UBS
    Buy
    May 2, 25 Canaccord Genuity
    Buy
    May 2, 25 B. Riley Securities
    Buy
    Apr 24, 25 JMP Securities
    Market Outperform
    Feb 27, 25 HC Wainwright & Co.
    Buy
    Feb 27, 25 Citigroup
    Buy
    Jan 14, 25 HC Wainwright & Co.
    Buy
    Jan 10, 25 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with MDGL included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Madrigal Pharmaceuticals, Inc.?
    • Does Madrigal Pharmaceuticals, Inc. pay dividends?
    • What sector is Madrigal Pharmaceuticals, Inc. in?
    • What industry is Madrigal Pharmaceuticals, Inc. in?
    • What country is Madrigal Pharmaceuticals, Inc. based in?
    • When did Madrigal Pharmaceuticals, Inc. go public?
    • Is Madrigal Pharmaceuticals, Inc. in the S&P 500?
    • Is Madrigal Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Madrigal Pharmaceuticals, Inc. in the Dow Jones?
    • When was Madrigal Pharmaceuticals, Inc.'s last earnings report?
    • When does Madrigal Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Madrigal Pharmaceuticals, Inc.?

    The ticker symbol for Madrigal Pharmaceuticals, Inc. is NASDAQ:MDGL

    Does Madrigal Pharmaceuticals, Inc. pay dividends?

    No, Madrigal Pharmaceuticals, Inc. does not pay dividends

    What sector is Madrigal Pharmaceuticals, Inc. in?

    Madrigal Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Madrigal Pharmaceuticals, Inc. in?

    Madrigal Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Madrigal Pharmaceuticals, Inc. based in?

    Madrigal Pharmaceuticals, Inc. is headquartered in United States

    When did Madrigal Pharmaceuticals, Inc. go public?

    Madrigal Pharmaceuticals, Inc.'s initial public offering (IPO) was on February 6, 2007

    Is Madrigal Pharmaceuticals, Inc. in the S&P 500?

    No, Madrigal Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Madrigal Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Madrigal Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Madrigal Pharmaceuticals, Inc. in the Dow Jones?

    No, Madrigal Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Madrigal Pharmaceuticals, Inc.'s last earnings report?

    Madrigal Pharmaceuticals, Inc.'s most recent earnings report was on August 5, 2025

    When does Madrigal Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Madrigal Pharmaceuticals, Inc. is October 30, 2025
    On this page